Whitehouse introduces Senate legislation targeting breast cancer

Capitol - 55.82 Kb
U.S. Senator Sheldon Whitehouse (D-R.I.) has introduced the Accelerating the End of Breast Cancer Act (S. 3237), legislation designed to establish a commission dedicated to completely eliminating breast cancer.

“This bill sets an ambitious goal of ending breast cancer by 2020, and will help drive our efforts going forward to put an end to this tragic disease,” Whitehouse said in a release.

The commission would identify promising research, encourage partnerships between government and the private sector and create opportunities for trans-disciplinary collaboration for ending the disease, according to Whitehouse’s office.

The bill is cosponsored by U.S. Senators Susan Collins (R-Maine), Sherrod Brown (D-Ohio), Lisa Murkowski (R-Ark.), Jeanne Shaheen (D-N.H.), Dean Heller (R-Nev.), Mark Warner (D-Va.), and Chuck Grassley (R-Iowa). It is also supported by the Rhode Island Breast Cancer Coalition.

A similar bill was introduced last year in the House by Rep. Karen Bass (D-Calif.). That bill, H.R. 3067, currently has 206 cosponsors.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.